TBG Diagnostics Dividenda 2024

Detalji o dividendama

Razumevanje dividendnih isplata od TBG Diagnostics

Dividende od TBG Diagnostics su deo profita kompanije koji se distribuira akcionarima. One su ključni indikator finansijskog zdravlja kompanije i atraktivnosti za investitore. Dividende pružaju investitorima stabilan izvor prihoda, pored dobiti koja se možda može ostvariti prodajom akcija po višoj ceni od kupovne.

Poređenje iz godine u godinu

Analiza isplata dividendi od TBG Diagnostics tokom godina može istaći profitabilnost i stabilnost kompanije. Konstantno ili rastuće isplate dividendi mogu ukazivati na finansijski zdravu kompaniju sa predvidivim profitom, dok fluktuacije ili smanjenja dividendi mogu signalizirati osnovne finansijske ili operativne izazove.

Uticaj na investicije

Isplate dividendi od TBG Diagnostics su suštinski faktor za investitore orijentisane na prihod. Robusna isplata dividendi može povećati privlačnost akcije i pružiti redovni prihod pored potencijalnih kapitalnih dobitaka. Ona može takođe pokazati poverenje kompanije u njene buduće profite i time biti značajan faktor za odlučivanje o investicijama.

Interpretacija fluktuacija dividendi

Promene u dividendama od TBG Diagnostics mogu proistići iz promena u profitima kompanije, finansijskoj politici ili strategijama reinvestiranja. Povećanje dividendi često signalizira finansijsku stabilnost, dok smanjenje može ukazivati na potrebu da se sačuva gotovina ili da se profiti reinvestiraju radi podsticanja rasta, pri čemu svaki scenario ima različite posledice za investitore.

TBG Diagnostics Aktienanalyse

Шта ради TBG Diagnostics?

TBG Diagnostics Ltd is an Australian company specializing in the manufacturing and marketing of in vitro diagnostic products. The company was originally founded in 2009 under the name TBG Biotechnology Pty Ltd and later became a corporation. The company's business model is to provide fast and reliable diagnostic solutions for various disease conditions. The company operates in various areas, including infectious diseases, diarrheal diseases, tumor diagnostics, cardiovascular diseases, and oncology. In the infectious diseases field, for example, TBG Diagnostics offers test kits for the diagnosis of HIV, hepatitis, dengue fever, and other infectious diseases. The test kits consist of immunological rapid tests that typically provide results within 15-20 minutes, allowing doctors to quickly make a diagnosis and initiate appropriate therapy. In the diarrheal diseases field, the company has developed a special test kit that allows for the detection of rotaviruses. Rotavirus infections are one of the most common causes of severe diarrhea in infants and can lead to serious complications if left untreated. TBG Diagnostics' tumor diagnostics division offers specialized test kits for the diagnosis of prostate cancer, breast cancer, and colorectal cancer. The test kits are based on the measurement of tumor markers in the blood and are a fast and non-invasive method for early cancer detection. The company's cardiovascular division offers test kits for the diagnosis of thyroid hormones and troponin. Troponin is a protein complex that is released into the blood in increased amounts when there is damage to the heart muscle and can be an indication of a heart attack. In collaboration with partners, TBG Diagnostics also develops innovative solutions for oncology. One example is a special test kit that enables personalized medicine for patients with advanced bladder cancer. The test kit analyzes the DNA of tumor cells and allows doctors to find individually tailored therapies for the patient. TBG Diagnostics is a successful company that has experienced steady growth in recent years. The company is listed on the Australian stock exchange and has a strong international distribution network, enabling it to distribute its products worldwide. Overall, TBG Diagnostics is a company specializing in the development and manufacturing of innovative diagnostic products. By focusing on various areas and collaborating with partners, the company can quickly respond to changing requirements in healthcare and offer customized solutions to its customers. TBG Diagnostics je jedna od najpopularnijih kompanija na Eulerpool.com.

Često postavljana pitanja o TBG Diagnostics akciji

Kolika je dividenda koju isplaćuje TBG Diagnostics?

U poslednjih 12 meseci, TBG Diagnostics je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, TBG Diagnostics će verovatno isplatiti dividendu od 0 AUD.

Kolika je dividendna prinosa za TBG Diagnostics?

Dividendski prinos od TBG Diagnostics trenutno iznosi .

Kada TBG Diagnostics isplaćuje dividendu?

TBG Diagnostics isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od TBG Diagnostics?

TBG Diagnostics je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije TBG Diagnostics?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 AUD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi TBG Diagnostics?

TBG Diagnostics se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von TBG Diagnostics kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od TBG Diagnostics od 5. 7. 2024. u iznosu od 0 AUD, morali ste da imate akciju u depou pre Ex-dana 5. 7. 2024..

Kada je TBG Diagnostics poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 5. 7. 2024..

Kolika je bila dividenda od TBG Diagnostics u godini 2023?

U godini 2023 kompanija TBG Diagnostics je isplatila 0 AUD kao dividende.

U kojoj valuti TBG Diagnostics isplaćuje dividendu?

Dividende od TBG Diagnostics se isplaćuju u AUD.